![Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection–induced ulcers? A randomized, prospective, multicenter study - Gastrointestinal Endoscopy Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection–induced ulcers? A randomized, prospective, multicenter study - Gastrointestinal Endoscopy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/87ed2a0a-2624-4f6a-9b5c-00ba2d552f61/gr1_lrg.jpg)
Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection–induced ulcers? A randomized, prospective, multicenter study - Gastrointestinal Endoscopy
![PDF] Administration of proton pump inhibitors in patients requiring enteral nutrition. | Semantic Scholar PDF] Administration of proton pump inhibitors in patients requiring enteral nutrition. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/86ce4119b0288e7ed72539da096fde0b73ad2e76/2-Table1-1.png)
PDF] Administration of proton pump inhibitors in patients requiring enteral nutrition. | Semantic Scholar
Structural Basis for Binding of Potassium-Competitive Acid Blockers to the Gastric Proton Pump | Journal of Medicinal Chemistry
![Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory | Scientific Reports Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-53622-3/MediaObjects/41598_2019_53622_Fig1_HTML.png)